CoChat
Sign Up
Cited by 271Inflammatory mediators and NSAID effectsSulfur Compounds in BiologyHydrogen's biological and therapeutic effects

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat

Wallace, John L., Caliendo, Giuseppe, Santagada, Vincenzo, Cirino, Giuseppe, Fiorucci, Stefano·2007·Gastroenterology
DOI 10.1053/j.gastro.2006.11.042
Open this paper in CoChat — free account

Abstract

Background & aims Gastrointestinal damage caused by nonsteroidal anti-inflammatory drugs (NSAIDs) remains a significant clinical problem. Hydrogen makes an important contribution to mucosal defense, and NSAIDs can suppress its synthesis. In this study, we evaluated the gastrointestinal safety and anti-inflammatory effects of a novel "HS-NSAID" (ATB-337) that consists of diclofenac linked to a hydrogen sulfide-releasing moiety.Methods The gastrointestinal injury-inducing effects of single or repeated administration of diclofenac versus ATB-337 were compared in rats, as were their effects on prostaglandin synthesis and cyclooxygenase-1 and -2 activities. The ability of these drugs to reduce carrageenan-induced paw edema and to elicit leukocyte adherence to the vascular endothelium (intravital microscopy) were also examined in rats.Results Diclofenac (10-50 micromol/kg) dose-dependently damaged the stomach, while ATB-337 did not. Repeated administration of diclofenac caused extensive small intestinal damage and reduced hematocrit by 50%. ATB-337 induced >90% less intestinal damage and had no effect on hematocrit. Diclofenac, but not ATB-337, elevated gastric granulocyte infiltration and expression of tumor necrosis factor alpha, lymphocyte function-associated antigen 1, and intercellular adhesion molecule 1. ATB-337 inhibited cycloxygenase-1 and cyclooxygenase-2 activity as effectively as diclofenac. ATB-337 did not induce leukocyte adherence, whereas diclofenac did, and was more potent at reducing paw edema.Conclusions An HS-NSAID spares the gastric mucosa of injury despite markedly suppressing prostaglandin synthesis. This effect may be related to hydrogen sulfide-mediated inhibition of tumor necrosis factor-alpha expression and of the leukocyte adherence to vascular endothelium normally induced by cyclooxygenase inhibitors.

Overview

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2006.11.042

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 39 references

Research works printed but not linked: 1

  1. Fiorucci, 2006, Enhanced anti-inflammatory activity of hydrogen sulfide releasing derivative of mesalamine in rodent models of colitis involves direct inhibition of Nf-KB (abstr), Gastroenterology, 130, A348

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Wallace, J. L., Caliendo, G., Santagada, V., Cirino, G., & Fiorucci, S.
Affiliations
  • University of Calgary (CA)
  • University of Naples Federico II (IT)
Corresponding author
Wallace, John L.
ORCID
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2007-01
Volume
132
Issue
1
Pages
261-271
ISSN
0016-5085 (ISSN-L)
DOI
10.1053/j.gastro.2006.11.042
OpenAlex
W2163895651
Cited by
271
References
39
Citations by year
2026: 6 · 2025: 3 · 2024: 6 · 2023: 9 · 2022: 13 · 2021: 13 · 2020: 12 · 2019: 13 · 2018: 9 · 2017: 23 · 2016: 19 · 2015: 26 · 2014: 23 · 2013: 22 · 2012: 18
FWCI
6.89
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Hydrogen's biological and therapeutic effects
Keywords
diclofenac, NSAID-induced gastrointestinal injury, gastroprotection, cyclooxygenase-1, cyclooxygenase-2, prostaglandin synthesis, TNF-α, leukocyte adhesion, paw edema, small bowel injury, hematocrit, anti-inflammatory activity
MeSH terms
Animals, Anti-Inflammatory Agents, Non-Steroidal, Blood Platelets, Diclofenac, Gastric Acid, Heterocyclic Compounds, 1-Ring, Humans, Hydrogen Sulfide, Male, Platelet Aggregation Inhibitors, Stomach, Drug Design, Cyclooxygenase Inhibitors, Rats, Wistar, Rats, Cyclooxygenase 1, Cyclooxygenase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review